Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Plant Biotechnology Journal

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1111/pbi.12244PMID 25229405PMCID PMC4620920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of a phage-display library of single-domain camelid VH H antibodies directed against Chlamydomonas reinhardtii antigens, and characterization of VH Hs binding cell-surface antigens.

  2013cited by this paper
• 27 High-value Recombinant Protein Production in Microalgae

  2013cited by this paper
• High-value Recombinant Protein Production in Microalgae

  2013cited by this paper
• Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.

  2013cited by this paper
• Alga-Produced Cholera Toxin-Pfs25 Fusion Proteins as Oral Vaccines

  2013cited by this paper
• Synthetic oligonucleotide libraries reveal novel regulatory elements in Chlamydomonas chloroplast mRNAs.

  2013cited by this paper
• Production of unique immunotoxin cancer therapeutics in algal chloroplasts

  2012cited by this paper
• Translational fusion and redirection to thylakoid lumen as strategies to improve the accumulation of a camelid antibody fragment in transplastomic tobacco

  2012cited by this paper
• Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission

  2012cited by this paper
• A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model

  2012cited by this paper
• Improved heterologous protein expression in the chloroplast of Chlamydomonas reinhardtii through promoter and 5' untranslated region optimization.

  2011cited by this paper
• A simple method for chloroplast transformation in Chlamydomonas reinhardtii.

  2011cited by this paper
• GM plants: science, politics and EC regulations.

  2010cited by this paper
• Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii.

  2010cited by this paper
• Antibody Protection against Botulinum Neurotoxin Intoxication in Mice

  2009cited by this paper
• Single-domain antibodies as building blocks for novel therapeutics.

  2008cited by this paper
• Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast.

  2007cited by this paper
• Human botulism immune globulin for the treatment of infant botulism.

  2006influential reference
• Induced refolding of a temperature denatured llama heavy‐chain antibody fragment by its antigen

  2005cited by this paper
• A simple method for chloroplast transformation in Chlamydomonas reinhardtii.

  2004cited by this paper
• Advances in the production of human therapeutic proteins in yeasts and filamentous fungi

  2004cited by this paper
• Botulinum toxin as a biological weapon

  2001cited by this paper
• Botulinum toxin as a biological weapon: medical and public health management.

  2001cited by this paper
• Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies.

  1999cited by this paper

• Modern strategies in nanobody engineering and functionalization: From discovery to biosensing application

  2026cites this paper
• Expression of recombinant Cap antigen of porcine circovirus type 2 in the chloroplast of Chlamydomonas reinhardtii

  2025cites this paper
• Charting the state of GEMs in microalgae: progress, challenges, and innovations

  2025cites this paper
• Recombinant Monoclonal Antibodies Synthesized in Plant Expression Systems: Problems and Prospects

  2024cites this paper
• Transgenesis in microalga Chlamydomonas reinhardtii: current approaches

  2024cites this paper
• Рекомбинантные моноклональные антитела, синтезируемые в растительных системах экспрессии: проблемы и перспективы

  2024cites this paper
• Harnessing the potential of microalgae for the production of monoclonal antibodies and other recombinant proteins

  2024cites this paper
• Biomanufacturing of glycosylated antibodies: Challenges, solutions, and future prospects.

  2023cites this paper
• Microalgae-based approaches to overcome the effects of the COVID-19 pandemic

  2022cites this paper
• Towards green biomanufacturing of high-value recombinant proteins using promising cell factory: Chlamydomonas reinhardtii chloroplast

  2022influential citation
• Algae in wastewater treatment, mechanism, and application of biomass for production of value-added product.

  2022cites this paper
• Harnessing the Algal Chloroplast for Heterologous Protein Production

  2022cites this paper
• Use of plant chloroplast RNA-binding proteins as orthogonal activators of chloroplast transgenes in the green alga Chlamydomonas reinhardtii

  2021cites this paper
• A review of plant-based expression systems as a platform for single-domain recombinant antibody production.

  2021cites this paper
• Advanced Applications for Protein and Compounds from Microalgae

  2021cites this paper
• Oral delivery of a functional algal-expressed TGF-β mimic halts colitis in a murine DSS model

  2021cites this paper
• A VHH-Fc Fusion Targeted to the Chloroplast Thylakoid Lumen Assembles and Neutralizes Enterohemorrhagic E. coli O157:H7

  2021cites this paper
• The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals

  2020cites this paper
• Microbial Photosynthesis

  2020cites this paper
• Emerging Technologies in Algal Biotechnology: Toward the Establishment of a Sustainable, Algae-Based Bioeconomy

  2020cites this paper
• Current advances in the algae-made biopharmaceuticals field

  2020cites this paper
• Applications of nanobodies in plant science and biotechnology

  2020cites this paper
• Photosynthetic Improvement of Industrial Microalgae for Biomass and Biofuel Production

  2020cites this paper
• Genome analysis and genetic transformation of a water surface-floating microalga Chlorococcum sp. FFG039

  2019cites this paper
• Cloning and expression of virus-like particles (VLPs) in microalgal expression systems

  2019cites this paper
• Nanobody and aptamer as targeting moiety against bacterial toxins: therapeutic and diagnostic applications

  2019cites this paper
• Algae biorefinery: Review on a broad spectrum of downstream processes and products.

  2019cites this paper
• Engineering microalgae through chloroplast transformation to produce high‐value industrial products

  2019cites this paper
• Utilizing genome-scale models to optimize nutrient supply for sustained algal growth and lipid productivity

  2019cites this paper
• Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches

  2019cites this paper
• The algal chloroplast as a synthetic biology platform for production of 1 therapeutic proteins 2 3

  2018cites this paper
• Strategies to improve Chlamydomonas reinhardtii as a recombinant protein host: from a small growth factor to a complex monoclonal antibody production

  2018cites this paper
• Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory

  2018cites this paper
• Prospects on the Use of Schizochytrium sp. to Develop Oral Vaccines

  2018cites this paper
• The algal chloroplast as a synthetic biology platform for production of therapeutic proteins.

  2018cites this paper
• Synthesis of recombinant antibacterial proteins in the Chlamydomonas reinhardtii chloroplast

  2018cites this paper
• Plastid Molecular Pharming I. Production of Oral Vaccines via Plastid Transformation.

  2017cites this paper
• From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein

  2017cites this paper
• Development of Synthetic Microbial Platforms to Convert Lignocellulosic Biomass to Biofuels

  2017cites this paper
• Engineering biosynthesis of high-value compounds in photosynthetic organisms

  2017cites this paper
• Antibody Production in Plants and Green Algae.

  2016cites this paper
• Perspectives for the Algae-Made Biopharmaceuticals Field

  2016cites this paper
• SINGLE DOMAIN ANTIBODIES AND BIOENGINEERING DRUGS ON THEIR BASIS: NEW OPPORTUNITIES FOR DIAGNOSTICS AND THERAPY

  2016cites this paper
• Expanding the toolkit of the Chlamydomonas reinhardtii chloroplast for biotechnological applications

  2016cites this paper
• Algae-Made Antibodies and Immunotoxins

  2016cites this paper
• Botulinum Neurotoxin, Tetanus Toxin, and Anthrax Lethal Factor Countermeasures

  2016cites this paper
• New tools for chloroplast genetic engineering allow the synthesis of human growth hormone in the green alga Chlamydomonas reinhardtii

  2016cites this paper
• Algae-Based Biopharmaceuticals

  2016cites this paper
• Microalgae as Solar-Powered Protein Factories.

  2016cites this paper
• Selenocystamine improves protein accumulation in chloroplasts of eukaryotic green algae

  2015cites this paper
• Biotechnological exploitation of microalgae.

  2015cites this paper
• Developing Chlamydomonas reinhardtii for recombinant therapeutic protein production

  2014cites this paper
• Evaluation of Antibiofilm and Cytotoxic Activity of Microalgae Isolated from Different Sites of betwata-Erbil/Iraq

  year unknowncites this paper